Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
  EC 3: Hydrolases
    EC 3.1
    EC 3.2
    EC 3.3
    EC 3.4
      EC 3.4.1
      EC 3.4.2
      EC 3.4.3
      EC 3.4.4
      EC 3.4.11
      EC 3.4.12
      EC 3.4.13
      EC 3.4.14
      EC 3.4.15
      EC 3.4.16
      EC 3.4.17
      EC 3.4.18
      EC 3.4.19
      EC 3.4.21
        EC 3.4.21.1
        EC 3.4.21.2
        EC 3.4.21.3
        EC 3.4.21.4
        EC 3.4.21.5
        EC 3.4.21.6
        EC 3.4.21.7
        EC 3.4.21.8
        EC 3.4.21.9
        EC 3.4.21.10
        EC 3.4.21.11
        EC 3.4.21.12
        EC 3.4.21.13
        EC 3.4.21.14
        EC 3.4.21.15
        EC 3.4.21.16
        EC 3.4.21.17
        EC 3.4.21.18
        EC 3.4.21.19
        EC 3.4.21.20
        EC 3.4.21.21
        EC 3.4.21.22
        EC 3.4.21.23
        EC 3.4.21.24
        EC 3.4.21.25
        EC 3.4.21.26
        EC 3.4.21.27
        EC 3.4.21.28
        EC 3.4.21.29
        EC 3.4.21.30
        EC 3.4.21.31
        EC 3.4.21.32
        EC 3.4.21.33
        EC 3.4.21.34
        EC 3.4.21.35
        EC 3.4.21.36
        EC 3.4.21.37
        EC 3.4.21.38
        EC 3.4.21.39
        EC 3.4.21.40
        EC 3.4.21.41
        EC 3.4.21.42
        EC 3.4.21.43
        EC 3.4.21.44
        EC 3.4.21.45
        EC 3.4.21.46
        EC 3.4.21.47
        EC 3.4.21.48
        EC 3.4.21.49
        EC 3.4.21.50
        EC 3.4.21.51
        EC 3.4.21.52
        EC 3.4.21.53
        EC 3.4.21.54
        EC 3.4.21.55
        EC 3.4.21.56
        EC 3.4.21.57
        EC 3.4.21.58
        EC 3.4.21.59
        EC 3.4.21.60
        EC 3.4.21.61
        EC 3.4.21.62
        EC 3.4.21.63
        EC 3.4.21.64
        EC 3.4.21.65
        EC 3.4.21.66
        EC 3.4.21.67
        EC 3.4.21.68
        EC 3.4.21.69
        EC 3.4.21.70
        EC 3.4.21.71
        EC 3.4.21.72
        EC 3.4.21.73
        EC 3.4.21.74
        EC 3.4.21.75
        EC 3.4.21.76
        EC 3.4.21.77
        EC 3.4.21.78
        EC 3.4.21.79
        EC 3.4.21.80
        EC 3.4.21.81
        EC 3.4.21.82
        EC 3.4.21.83
        EC 3.4.21.84
        EC 3.4.21.85
        EC 3.4.21.86
        EC 3.4.21.87
        EC 3.4.21.88
        EC 3.4.21.89
        EC 3.4.21.90
        EC 3.4.21.91
        EC 3.4.21.92
        EC 3.4.21.93
        EC 3.4.21.94
        EC 3.4.21.95
        EC 3.4.21.96
        EC 3.4.21.97
        EC 3.4.21.98
        EC 3.4.21.99
        EC 3.4.21.100
        EC 3.4.21.101
        EC 3.4.21.102
        EC 3.4.21.103
        EC 3.4.21.104
        EC 3.4.21.105
        EC 3.4.21.106
        EC 3.4.21.107
        EC 3.4.21.108
        EC 3.4.21.109
        EC 3.4.21.110
        EC 3.4.21.111
        EC 3.4.21.112
        EC 3.4.21.113
        EC 3.4.21.114
        EC 3.4.21.115
        EC 3.4.21.116
        EC 3.4.21.117
        EC 3.4.21.118
        EC 3.4.21.119
        EC 3.4.21.120
      EC 3.4.22
      EC 3.4.23
      EC 3.4.24
      EC 3.4.25
      EC 3.4.99
    EC 3.5
    EC 3.6
    EC 3.7
    EC 3.8
    EC 3.9
    EC 3.10
    EC 3.11
    EC 3.12
    EC 3.13
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 3.4.21.21 - coagulation factor VIIa



3D structures of EC 3.4.21.21 - coagulation factor VIIa in Protein Data Bank

updated: 27 November 2021, 5:15

In total: 105 PDB structures of EC 3.4.21.21 - coagulation factor VIIa:
  1. 1bf9: N-terminal Egf-like Domain from Human Factor Vii, Nmr, 23 Structures
  2. 1cvw: Crystal Structure of Active Site-inhibited Human Coagulation Factor Viia (des-gla)
  3. 1dan: Complex of Active Site Inhibited Human Blood Coagulation Factor Viia with Human Recombinant Soluble Tissue Factor
  4. 1dva: Crystal Structure of The Complex between The Peptide Exosite Inhibitor E-76 and Coagulation Factor Viia
  5. 1fak: Human Tissue Factor Complexed with Coagulation Factor Viia Inhibited with a Bpti-mutant
  6. 1jbu: Coagulation Factor VII Zymogen (egf2/protease) in Complex with Inhibitory Exosite Peptide A-183
  7. 1kli: Cofactor-and Substrate-assisted Activation of Factor Viia
  8. 1klj: Crystal Structure of Uninhibited Factor Viia
  9. 1o5d: Dissecting and Designing Inhibitor Selectivity Determinants at The S1 Site Using an Artificial Ala190 Protease (ala190 Upa)
  10. 1qfk: Structure of Human Factor Viia and Its Implications for The Triggering of Blood Coagulation
  11. 3ela: Crystal Structure of Active Site Inhibited Coagulation Factor Viia Mutant in Complex with Soluble Tissue Factor
  12. 1w0y: TF7A_3771 Complex
  13. 1w2k: TF7A_4380 Complex
  14. 1w7x: Factor7- 413 Complex
  15. 1w8b: Factor7 - 413 Complex
  16. 2zzu: Human Factor Viia-tissue Factor Complexed with Ethylsulfonamide-d-5-(3-carboxybenzyloxy)-trp-gln-p- Aminobenzamidine
  17. 2zwl: Human Factor Viia-tissue Factor Complexed with Highly Selective Peptide Inhibitor
  18. 1wqv: Human Factor Viia-tissue Factor Complexed with Propylsulfonamide-d-thr-met-p-aminobenzamidine
  19. 2zp0: Human Factor Viia-tissue Factor Complexed with Benzylsulfonamide-d-ile-gln-p-aminobenzamidine
  20. 1wss: Human Factor Viia-tissue Factor in Complex with Peprid Mimetic Inhibitor That Has Two Charge Groups in P2 and P4
  21. 1wtg: Human Factor Viia-tissue Factor Complexed with Ethylsulfonamide-d-biphenylalanine-gln-p-aminobenzamidine
  22. 1wun: Human Factor Viia-tissue Factor Complexed with Ethylsulfonamide-d-trp-gln-p-aminobenzamidine
  23. 1wv7: Human Factor Viia-tissue Factor Complexed with Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
  24. 1ygc: Short Factor Viia with a Small Molecule Inhibitor
  25. 1z6j: Crystal Structure of a Ternary Complex of Factor Viia/tissue Factor/pyrazinone Inhibitor
  26. 2a2q: Complex of Active-site Inhibited Human Coagulation Factor Viia with Human Soluble Tissue Factor in The Presence of Ca2+, Mg2+, Na+, and Zn2+
  27. 2aei: Crystal Structure of a Ternary Complex of Factor Viia/tissue Factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]- 3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2- Pyridinyl]oxy]-benzoic Acid
  28. 2aer: Crystal Structure of Benzamidine-factor Viia/soluble Tissue Factor Complex.
  29. 2b7d: Factor Viia Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model
  30. 2b8o: Crystal Structure of Glu-gly-arg-chloromethyl Ketone-factor Viia/soluble Tissue Factor Complex
  31. 2bz6: Orally Available FACTOR7A Inhibitor
  32. 2c4f: Crystal Structure of Factor Vii.stf Complexed with Pd0297121
  33. 2puq: Crystal Structure of Active Site Inhibited Coagulation Factor Viia in Complex with Soluble Tissue Factor
  34. 2ec9: Crystal Structure Analysis of Human Factor Viia , Souluble Tissue Factor Complexed with Bcx-3607
  35. 2f9b: Discovery of Novel Heterocyclic Factor Viia Inhibitors
  36. 2fir: Crystal Structure of Dfpr-viia/stf
  37. 2flr: Novel 5-azaindole Factor Viia Inhibitors
  38. 6r2w: Crystal Structure of The Super-active Fviia Variant Vyt in Complex with Tissue Factor
  39. 3th2: Mg2+ Is Required for Optimal Folding of The Gamma-carboxyglutamic Acid (gla) Domains of Vitamin K-dependent Clotting Factors at Physiological Ca2+
  40. 3th3: Mg2+ Is Required for Optimal Folding of The Gamma-carboxyglutamic Acid (gla) Domains of Vitamin K-dependent Clotting Factors at Physiological Ca2+
  41. 3th4: Mg2+ Is Required for Optimal Folding of The Gamma-carboxyglutamic Acid (gla) Domains of Vitamin K-dependent Clotting Factors at Physiological Ca2+
  42. 4isi: Structure of Factor Viia in Complex with The Inhibitor (6s)-n-(4- Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,8-diethyl-4-oxo- 4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
  43. 4ish: Structure of Factor Viia in Complex with The Inhibitor Bms-593214 Also Known as 2'-[(6r,6ar,11br)-2-carbamimidoyl-6,6a,7,11b-tetrahydro-5h- Indeno[2,1-c]quinolin-6-yl]-5'-hydroxy-4'-methoxybiphenyl-4- Carboxylic Acid
  44. 4jyu: Structure of Factor Viia in Complex with The Inhibitor (2r)-2-[(1- Aminoisoquinolin-6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n- (phenylsulfonyl)ethanamide
  45. 4jyv: Structure of Factor Viia in Complex with The Inhibitor (2r)-2-[3- Ethoxy-4-(propan-2-yloxy)phenyl]-2-(isoquinolin-6-ylamino)-n-[(3- Sulfamoylphenyl)sulfonyl]ethanamide
  46. 4ibl: Rubidium Sites in Blood Coagulation Factor Viia
  47. 4jzd: Structure of Factor Viia in Complex with The Inhibitor 2-{2-[(4- Carbamimidoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1- Hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic Acid
  48. 4jze: Structure of Factor Viia in Complex with The Inhibitor 2-{2-[(1- Aminoisoquinolin-6-yl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1- Hydroxy-3,3-dimethylbutan-2-yl]carbamoyl}benzoic Acid
  49. 4jzf: Structure of Factor Viia in Complex with The Inhibitor 2-{2-[(3- Carbamoylphenyl)carbamoyl]-6-methoxypyridin-3-yl}-5-{[(2s)-1-hydroxy- 3,3-dimethylbutan-2-yl]carbamoyl}benzoic Acid
  50. 4na9: Factor Viia in Complex with The Inhibitor 3'-amino-5'-[(2s,4r)-6- Carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2- Carboxylic Acid
  51. 4ng9: Factor Viia in Complex with The Inhibitor (2r)-2-[(1-aminoisoquinolin- 6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-(3- Sulfamoylbenzyl)ethanamide
  52. 4nga: Factor Viia in Complex with The Inhibitor (2r)-2-[(1-aminoisoquinolin- 6-yl)amino]-2-[3-ethoxy-4-(propan-2-yloxy)phenyl]-n-[2-(propan-2- Ylsulfonyl)benzyl]ethanamide
  53. 5u6j: Factor Viia in Complex with The Inhibitor 3-{[(2r)-17-ethyl-4-methyl- 3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11- Diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2- Yl]amino}benzamide
  54. 5tqg: Factor Viia in Complex with The Inhibitor (5r,11r)-11-[(1-amino-4- Fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2- Difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6, 10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione
  55. 5tqf: Factor Viia in Complex with The Inhibitor (11r)-11-[(1- Aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13- Diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3, 12-dione
  56. 5tqe: Factor Viia in Complex with The Inhibitor (5r)-5-[(1-aminoisoquinolin- 6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15- Diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene- 4,14-dione
  57. 5pb6: Crystal Structure of Factor Viia in Complex with N-[[3-[5-hydroxy-4- (1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]pentanamide
  58. 5pb5: Human Factor Viia in Complex with 1-[[3-[5-hydroxy-4-(7h-pyrrolo[2,3- D]pyrimidin-6-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 1.84a
  59. 5pb4: Human Factor Viia in Complex with 1-[[3-[5-hydroxy-3-methyl-4-(1h- Pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 2.43a
  60. 5pb3: Crystal Structure of Factor Viia in Complex with 1-[[3-[4-(5-amino-1h- Pyrrolo[3,2-b]pyridin-2-yl)-5-hydroxypyrazol-1-yl]phenyl]methyl]-3- Phenylurea
  61. 5pb2: Crystal Structure of Factor Viia in Complex with 2-phenyl-4-(1h- Pyrrolo[3,2-c]pyridin-2-yl)pyrazol-3-ol
  62. 5pb1: Crystal Structure of Factor Viia in Complex with Benzenecarboximidamide
  63. 5pb0: Crystal Structure of Factor Viia in Complex with 2-(4-ethoxy-3- Methoxyphenyl)-2-(isoquinolin-6-ylamino)acetic Acid
  64. 5pay: Crystal Structure of Factor Viia in Complex with 1-[[3-[5-hydroxy-4- (1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3- Phenylurea
  65. 5pax: Crystal Structure of Factor Viia in Complex with 1-(2,6- Difluorophenyl)-3-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl) Pyrazol-1-yl]phenyl]methyl]urea
  66. 5paw: Crystal Structure of Factor Viia in Complex with Isoquinoline-1,6- Diamine
  67. 5pav: Crystal Structure of Factor Viia in Complex with N-(6-aminopyridin-3- Yl)-5-hydroxy-1-phenylpyrazole-4-carboxamide
  68. 5pau: Crystal Structure of Factor Viia in Complex with N-(2-amino-1h- Benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)- Methylsulfonylamino]phenyl]acetamide;2,2,2-trifluoroacetic Acid
  69. 5pat: Crystal Structure of Factor Viia in Complex with N-(2-amino-1h- Benzimidazol-5-yl)-2-(3-chlorophenyl)acetamide
  70. 5pas: Crystal Structure of Factor Viia in Complex with (2s)-2-hydroxy-n-[[3- [5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- Yl]phenyl]methyl]-3-phenylpropanamide
  71. 5par: Crystal Structure of Factor Viia in Complex with 1h-benzimidazol-2- Amine
  72. 5paq: Crystal Structure of Factor Viia in Complex with 2-[(1- Aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-propan-2-yloxyphenyl)-1- (2-phenylpyrrolidin-1-yl)ethanone
  73. 5pao: Crystal Structure of Factor Viia in Complex with (2s)-2,3-dihydroxy-n- [[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- Yl]phenyl]methyl]propanamide;hydrobromide
  74. 5pan: Crystal Structure of Factor Viia in Complex with 5-hydroxy-n-(3-oxo-1, 2-dihydroisoindol-5-yl)-1-[3-[(phenylcarbamoylamino) Methyl]phenyl]pyrazole-4-carboxamide
  75. 5pam: Crystal Structure of Factor Viia in Complex with 2-[(1- Aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-fluorophenyl)-1-(2- Phenylpyrrolidin-1-yl)ethanone
  76. 5pak: Crystal Structure of Factor Viia in Complex with N-[[4-(aminomethyl)- 2-(2-amino-2-oxoethoxy)phenyl]methyl]-2-(4-hydroxyphenyl)-2- Methoxyacetamide;hydrochloride
  77. 5paj: Crystal Structure of Factor Viia in Complex with 1-(1- Aminoisoquinolin-6-yl)-3-benzylurea
  78. 5pai: Human Factor Viia in Complex with N-(2-amino-1h-benzimidazol-5-yl)-1- [3-[[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]methyl]phenyl]-5- Hydroxypyrazole-4-carboxamide at 1.73a
  79. 5pag: Crystal Structure of Factor Viia in Complex with (2r)-2-hydroxy-n-[[3- [5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- Yl]phenyl]methyl]-3-methylbutanamide;hydrobromide
  80. 5paf: Crystal Structure of Factor Viia in Complex with N-(2-amino-1h- Benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]-5- Chlorophenyl]acetamide;2,2,2-trifluoroacetic Acid
  81. 5pae: Crystal Structure of Factor Viia in Complex with (2s)-2-hydroxy-n-[[3- [5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- Yl]phenyl]methyl]propanamide
  82. 5pac: Human Factor Viia in Complex with 5-hydroxy-n-(4-oxo-3h-quinazolin-6- Yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide at 1.50a
  83. 5pab: Crystal Structure of Factor Viia in Complex with 1-[[3-[2-hydroxy-3- (1h-pyrrolo[3,2-c]pyridin-2-yl)phenyl]phenyl]methyl]-3-phenylurea
  84. 5paa: Crystal Structure of Factor Viia in Complex with Cyclohexylmethanamine
  85. 5pa9: Crystal Structure of Factor Viia in Complex with Phenylmethanamine;hydrochloride
  86. 5pa8: Crystal Structure of Factor Viia in Complex with Cyclohexanamine
  87. 5l30: Factor Viia in Complex with The Inhibitor (2r,15r)-2-[(1- Aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1h-tetrazol-5- Yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa- 1(18),6(21),7,9,16,19-hexaene-3,12-dione
  88. 5l2z: Factor Viia in Complex with The Inhibitor 1-[(2r,15r)-2-[(1-amino-4- Fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4, 11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19- Hexaen-7-yl]cyclohexane-1-carboxylic Acid
  89. 5l2y: Factor Viia in Complex with The Inhibitor 1-[(2r,15r)-2-[(1-amino-4- Fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4, 11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19- Hexaen-7-yl] Cyclobutane-1-carboxylic Acid
  90. 5l0s: Human Poglut1 in Complex with Factor VII Egf1 and Udp
  91. 5ky3: Mouse Pofut1 in Complex with Mouse Factor VII Egf1 Mutant (T101A) and Gdp-fucose
  92. 5ky2: Mouse Pofut1 in Complex with O-glucosylated Mouse Factor VII Egf1 and Gdp
  93. 5kxh: Mouse Pofut1 in Complex with Mouse Factor VII Egf1 and Gdp
  94. 5i46: Factor Viia in Complex with The Inhibitor (2r,15r)-2-[(1- Aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13- Oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19- Hexaene-3,12-dione
  95. 4zxy: Factor Viia in Complex with The Inhibitor (2r)-2-[(1-aminoisoquinolin- 6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7, 9,16,19-hexaene-3,12-dione
  96. 4zxx: Factor Viia in Complex with The Inhibitor N-{3-[(2r)-1-{(2r)-2-[(1- Aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4- (propan-2-ylsulfonyl)phenyl}acetamide
  97. 4zma: Crystal Structure of a Fviia-trypsin Chimera (st) in Complex with Soluble Tissue Factor
  98. 4z6a: Crystal Structure of a Fviia-trypsin Chimera (yt) in Complex with Soluble Tissue Factor
  99. 4x8s: Factor Viia in Complex with The Inhibitor 4-bromo-2-methoxyphenol
  100. 4x8t: Factor Viia in Complex with The Inhibitor 7-chloro-3,4- Dihydroisoquinolin-1(2h)-one
  101. 4x8u: Factor Viia in Complex with The Inhibitor 5-chloro-1h-indole-2- Carboxylic Acid
  102. 4x8v: Factor Viia in Complex with The Inhibitor (methyl {3-[(2r)-1-{(2r)-2- (3,4-dimethoxyphenyl)-2-[(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl) Amino]acetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl) Phenyl}carbamate)
  103. 4ylq: Crystal Structure of a Fviia-trypsin Chimera (ft) in Complex with Soluble Tissue Factor
  104. 4yt6: Factor Viia in Complex with The Inhibitor 4-{[(r)-[5-ethoxy-2-fluoro- 3-(propan-2-yloxy)phenyl](4-phenyl-1h-imidazol-2-yl) Methyl]amino}benzenecarboximidamide
  105. 4yt7: Factor Viia in Complex with The Inhibitor 2-(2-{(r)-[(4- Carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy) Phenyl]methyl}-1h-imidazol-4-yl)benzamide
© Copyright 2008-2009 by enzymes.me.uk